Naba, Alexandra http://orcid.org/0000-0002-4796-5614
Article History
Accepted: 16 July 2024
First Online: 2 September 2024
Competing interests
: The Naba laboratory holds a sponsored research agreement with Boehringer-Ingelheim for work not related to the content of this manuscript. A.N. holds a consulting agreement with XM Therapeutics, AbbVie, and RA Capital.